In summary, this single-institutional, retrospective study showed that in patients with lung adenocarcinoma and BM, upfront BRT was associated with a significantly longer intracranial PFS, especially in patients without EGFR (19 or 21) mutation. Here, EGFR is linked to lung adenocarcinoma.